dr. mesa on new trials and agents in the pipeline in myelofibrosis
Published 4 years ago • 86 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
1:33
dr. mesa on late-stage trials in myelofibrosis
-
1:36
dr. mesa gives an overview of upcoming trials in myelofibrosis
-
1:42
dr. mesa on ruxolitinib vs fedratinib in myelofibrosis treatment
-
30:30
dr ruben mesa-myelofibrosis and advancing mpns: current and future approaches
-
0:59
dr. michaelis on fedratinib in myelofibrosis treatment
-
1:07
dr. garcia on the role of navitoclax in myelofibrosis
-
2:00
dr. mascarenhas on approved and emerging treatment options in myelofibrosis
-
1:08
dr. kremyanskaya on responses with cpi-0610 in patients with myelofibrosis
-
1:00
dr. kremyanskaya on effect of cpi-0610 in patients with myelofibrosis
-
1:08
dr. tefferi on the toxicity profile of imetelstat
-
1:19
dr. gerds on luspatercept to treat anemia in myelofibrosis
-
1:51
dr. snyder on transplant updates in myelofibrosis
-
1:31
dr. kuykendall on toxicity profiles of ruxolitinib and fedratinib in myelofibrosis
-
2:28
meet the pardee cardiologists | martin sullivan, md, facc
-
5:33
an mpn expert defines clinical trial types
-
1:36
clinical trials evaluating novel agents in mds: select-mds-1
-
41:57
new research & clinical trials
-
1:50
sander florman, md
-
1:03
s. andrew josephson, md